GLENMARK PHARMACEUTICALS
|
The Current P/S Ratio of GLENMARK PHARMACEUTICALS is 3.23.
Share Price | ₹1,399.9 | Jan 28,2025 |
Market Cap | ₹39,503.8 Cr | |
Sales-TTM | ₹12,247.6 Cr | TTM-Consolidated Results |
Price/Sales | 3.23x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLENMARK PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹39,503.8 Cr] as on Jan 28,2025
(/) Sales [ ₹12,247.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.23x ]
Thus, for GLENMARK PHARMACEUTICALS , the investors are currently willing to pay '3.23 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLENMARK PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of GLENMARK PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of GLENMARK PHARMACEUTICALS
PS Ratio Performance Analysis for GLENMARK PHARMACEUTICALS
- GLENMARK PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.24x.
- GLENMARK PHARMACEUTICALS 's operated at median p/e ratio of 1.13x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLENMARK PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 2.29x.
- GLENMARK PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.55x.
How does GLENMARK PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLENMARK PHARMACEUTICALS | 12,247.6 | 3.23 | 39,503.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.14 | 409,303.0 |
CIPLA LTD | 26,981.2 | 4.25 | 114,645.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.15 | 98,449.5 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.26 | 91,587.4 |
DIVIS LABORATORIES LTD | 8,614.0 | 16.65 | 143,389.0 |
MANKIND PHARMA LTD | 11,641.0 | 8.71 | 101,440.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.92 | 112,169.0 |
LUPIN LTD | 21,431.3 | 4.31 | 92,321.3 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.18 | 66,080.7 |
ABBOTT INDIA LTD | 6,066.1 | 9.02 | 54,708.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLENMARK PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.18x |
Max industry PS | 16.65x |
Median industry PS | 4.31x |
Average industry PS | 6.71x |
You may also like the below Video Courses